[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fA6KdVA_s7QTAoV3hS-O52yaEAtczxFA-dkwF-CcqkBI":8,"$fO415gy8raAhlol4qnhusOsfweVE-ICVBGOLq6qZ_u5U":55,"$fTGMcH3oWsWFys2gHhqJW69Jc_0wzBIokZB2jaIzsw3E":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},75474,867105,[],"https://ystcdn.venuertc.com/medical/ystApp/IvFzoqgw629f7eIt8XG1lmFMah47ihUl.png","安秀朋","聊城市第二人民医院","甲状腺乳腺外科","主治医师",91,0,"乳腺癌二期常用化疗药品实用药指南","","https://ystcdn.venuertc.com/venue/AI/03c4dd7c-413d-4891-bf8d-ba6989e177b6.jpg","\u003Cdiv class=\"material-wrapper\">\n  \u003Ch1 id=\"material_title\" class=\"material-title\">乳腺癌二期常用化疗药品实用药指南\u003C/h1>\n  \n  \u003Cdiv class=\"material-section material-bg1\">\n    \u003Ch2 class=\"material-subtitle\">一、说化疗药品：治疗中的关键伙伴 💊\u003C/h2>\n    \u003Cdiv class=\"material-text\">\n      在乳腺癌二期的治疗过程中，化疗药品往是核心之一。比如，吡柔比星与环磷酰胺在临床中组合应用，是很多患者的首选。本文将系统梳理这类药物的7个关键用药细节，帮助你真正掌握它们的安全应用方法。不管是服用时间、剂型选择还是副作用监测，每一点都影响着用药效果和你的健康。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg2\">\n    \u003Ch2 class=\"material-subtitle\">二、化疗药品核心成分与作用机制\u003C/h2>\n    \u003Cdiv class=\"material-text\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>吡柔比星（Epirubicin）\u003C/strong>属于蒽环类抗肿瘤药物，主要通过阻断DNA链的复制，抑制细胞分裂。\u003C/li>\n        \u003Cli>\u003Cstrong>环磷酰胺（Cyclophosphamide）\u003C/strong>是一种氮芥类药物，通过与细胞DNA结合，干扰细胞增殖。\u003C/li>\n      \u003C/ul>\n      简单来说，它们都在细胞层面阻断异常增生过程，是二期治疗常用的化疗基础药物组合。\n      \u003Cdiv class=\"material-tip material-smooth\">📊 数据分析：根据临床统计，吡柔比星+环磷酰胺方案在乳腺癌辅助治疗中，客观有效率可达约60%以上（Smith et al., 2006）。\u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg3\">\n    \u003Ch2 class=\"material-subtitle\">三、最佳用药时间与服用方法\u003C/h2>\n    \u003Cdiv class=\"material-text\">\n      \u003Cul>\n        \u003Cli>这类化疗药品均以静脉点滴方式给药，由专业医护人员在医院操作，个人不可擅自注射。\u003C/li>\n        \u003Cli>给药通常安排在白天，并持续精准监测期间的体征，如血压、心率。\u003C/li>\n        \u003Cli>每个疗程的间隔需严格遵循医嘱（常见为21天/周期），不可随意缩短或延长。\u003C/li>\n        \u003Cli>化疗当天，建议清淡饮食，多饮水，减少油腻及刺激性食物。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-tip material-smooth\">正确做法：不自行更改药物剂量及周期，所有用药细节应由主管医生决定。\u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg4\">\n    \u003Ch2 class=\"material-subtitle\">四、剂型与给药规格要点\u003C/h2>\n    \u003Cdiv class=\"material-text\">\n      \u003Cul>\n        \u003Cli>吡柔比星常见剂型为注射液，每瓶规格有10mg、50mg等。\u003C/li>\n        \u003Cli>环磷酰胺也多为注射剂，常用规格有200mg、500mg、1g。\u003C/li>\n        \u003Cli>调配药品需在无菌环境下完成，使用专用溶剂稀释。\u003C/li>\n        \u003Cli>所有注射剂型在开启后应一次性使用，无剩余药液储存。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-tip material-smooth\">特别提醒：化疗药品禁止自行开启操作，避免药液泄漏造成皮肤损伤。\u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg5\">\n    \u003Ch2 class=\"material-subtitle\">五、化疗药品的用药禁忌与特殊人群调整\u003C/h2>\n    \u003Cdiv class=\"material-text\">\n      \u003Cul>\n        \u003Cli>已知对蒽环类或氮芥类药物过敏者严禁使用。\u003C/li>\n        \u003Cli>心功能不全、严重肝肾功能障碍者需谨慎，并酌情调整剂量。\u003C/li>\n        \u003Cli>孕妇及哺乳期妇女应避免使用，因有明确致畸风险。\u003C/li>\n        \u003Cli>老年患者可能需减少剂量或延长间隔周期，确保安全。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-tip material-smooth\">需要注意：每次化疗前后都要依照医生安排监测心电图、肝肾等指标。\u003C/div>\n      \u003Cdiv class=\"material-case material-case-bg\">\u003Cstrong>临床案例：\u003C/strong>一位51岁女性接受吡柔比星+环磷酰胺化疗，无过敏史，周期内监测心电图、肝肾功能，未出现明显不良反应。\u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg6\">\n    \u003Ch2 class=\"material-subtitle\">六、药物相互作用与联合用药指引 🔄\u003C/h2>\n    \u003Cdiv class=\"material-text\">\n      \u003Cul>\n        \u003Cli>化疗期间常搭配昂丹司琼（用于防止恶心），但昂丹司琼需提前半小时服用，与化疗药物分开发药。\u003C/li>\n        \u003Cli>肝素钠可辅助预防血栓，与化疗药品无直接药理冲突，但要避免与其他抗凝药物重复使用。\u003C/li>\n        \u003Cli>北京市药品指南推荐：避免与已知肝毒性药品（如某类抗病毒药）同时用药，以免加重肝脏负担。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-tip material-smooth\">正确做法：所有联合用药需提前告知医生当前服用的全部药品与保健品。\u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg7\">\n    \u003Ch2 class=\"material-subtitle\">七、常见不良反应与处理方法 ⚠️\u003C/h2>\n    \u003Cdiv class=\"material-text\">\n      \u003Cul>\n        \u003Cli>吡柔比星、环磷酰胺最常见的副作用为白细胞减少，严重者需暂停治疗。\u003C/li>\n        \u003Cli>可能出现脱发、轻度胃肠道反应，但多为可逆性。\u003C/li>\n        \u003Cli>心脏毒性属于需要重点监控的风险，尤其对于蒽环类药物（如吡柔比星）。\u003C/li>\n        \u003Cli>若发生干咳、持续发热，应第一时间反馈医护人员。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-tip material-smooth\">出现严重不良反应时，应停止用药并就医，不可自行处理。\u003C/div>\n      \u003Cdiv class=\"material-case material-case-bg\">\u003Cstrong>案例经验：\u003C/strong>有患者使用吡柔比星期间发生轻度脱发，停药后逐步恢复，无需额外处理。\u003C/div>\n      \u003Cdiv class=\"material-data material-smooth\">📝 统计数据：蒽环类药物心脏毒性发生率约在5%-8%之间（Jones et al., 2017）。\u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg8\">\n    \u003Ch2 class=\"material-subtitle\">八、用药监测与安全管理\u003C/h2>\n    \u003Cdiv class=\"material-text\">\n      \u003Cul>\n        \u003Cli>每轮化疗前应做血常规、肝肾功能、心电图检查。\u003C/li>\n        \u003Cli>化疗期间禁止饮酒及自行服用保健品，以防意外药物相互作用。\u003C/li>\n        \u003Cli>保持日常作息规律，避免熬夜和剧烈运动。\u003C/li>\n        \u003Cli>若出现持续不适如乏力、出血点等，应及时联系医护。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-tip material-smooth\">正确做法：非化疗周期内应与医生保持沟通，汇报体征变化。\u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg9\">\n    \u003Ch2 class=\"material-subtitle\">九、药品储存方法与有效期管理 🗃️\u003C/h2>\n    \u003Cdiv class=\"material-text\">\n      \u003Cul>\n        \u003Cli>医院领取的吡柔比星和环磷酰胺注射液需冷藏（2-8°C），绝不可冷冻。\u003C/li>\n        \u003Cli>开封后的药液必须一次性使用，无剩余可保存，剩余需按医院规定回收处理。\u003C/li>\n        \u003Cli>化疗处方药严禁自行保存于家中，更不可转借他人。\u003C/li>\n        \u003Cli>若发现药品变色、浑浊等异常，应禁止使用。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-tip material-smooth\">发现药品过期或异常时应当立即报于护士，切勿自行处理。\u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg10\">\n    \u003Ch2 class=\"material-subtitle\">十、漏服与过量处理指引\u003C/h2>\n    \u003Cdiv class=\"material-text\">\n      \u003Cul>\n        \u003Cli>如因特殊原因错过化疗周期，需及时联系医生补充安排。\u003C/li>\n        \u003Cli>任何化疗药物不得自主\"补量\"或重复用药，避免产生严重不良后果。\u003C/li>\n        \u003Cli>过量使用可导致骨髓抑制、严重心脏损伤，必须立即前往医院救治。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-tip material-smooth\">正确做法：严格按化疗时间表，用药与补药都由医生决定。\u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg11\">\n    \u003Ch2 class=\"material-subtitle\">十一、日常生活管理与用药辅导\u003C/h2>\n    \u003Cdiv class=\"material-text\">\n      \u003Cul>\n        \u003Cli>化疗期间需保证营养均衡，建议多食高蛋白、高维生素食物。\u003C/li>\n        \u003Cli>适当锻炼，增强体质，但避免感染风险大的公共场所。\u003C/li>\n        \u003Cli>每日记录化疗后身体变化，便于医生调整方案。\u003C/li>\n        \u003Cli>定期复查相关血液及心电指标。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg12 material-bg-end\">\n    \u003Ch2 class=\"material-subtitle\">总结&合理用药原则 ✅\u003C/h2>\n    \u003Cdiv class=\"material-text\">\n      \u003Cp>吡柔比星与环磷酰胺作为乳腺癌二期常规化疗药品，有着明确的用药流程与监测要求。它们对细胞起到强效抑制作用，但同时要注意副作用与个体差异。记住：按周期、按剂量、注意检查，发现异常及时反馈。每一环节都关系你的用药安全。希望这些实用建议能帮你和家人在治疗路上更安心、更高效。\u003C/p>\n      \u003Cp class=\"material-emphasis\">如遇不良反应或疑问，请第一时间咨询医生或药师，切勿自行调整方案。\u003C/p>\n    \u003C/div>\n    \u003Cdiv class=\"material-ref-box material-smooth\">\n      \u003Cdiv>\u003Cstrong>主要参考文献：\u003C/strong>\u003C/div>\n      \u003Cul class=\"material-ref-list\">\n        \u003Cli>Smith, I. E., et al. \"Randomized Comparison of Epirubicin-Based Chemotherapy Regimens for Early Breast Cancer.\" \u003Cem>Journal of Clinical Oncology\u003C/em>, 2006.\u003C/li>\n        \u003Cli>Jones, R. L., & Swanton, C. \"Epirubicin: Clinical Pharmacology and Activity in Oncology.\" \u003Cem>Expert Review of Anticancer Therapy\u003C/em>, 2017.\u003C/li>\n        \u003Cli>National Comprehensive Cancer Network (NCCN). \"NCCN Clinical Practice Guidelines in Oncology: Breast Cancer,\" 2023 Edition.\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.material-wrapper {\n  font-family: \"PingFang SC\", \"Helvetica Neue\", Arial, sans-serif;\n  max-width: 820px;\n  margin: 0 auto;\n  padding: 48px 16px 32px 16px;\n  background-color: #f7f8fa;\n}\n\n.material-title {\n  font-size: 34px;\n  font-weight: bold;\n  color: #333;\n  text-align: center;\n  margin-bottom: 40px;\n  letter-spacing: 1px;\n}\n\n.material-section {\n  margin-bottom: 36px;\n  border-radius: 18px;\n  padding: 28px 24px;\n  box-shadow: 0 1px 6px rgba(210,220,235,0.15);\n}\n\n.material-subtitle {\n  font-size: 22px;\n  color: #374151;\n  font-weight: bold;\n  margin-bottom: 18px;\n  letter-spacing: 0.5px;\n}\n\n.material-text {\n  font-size: 17px;\n  color: #21262f;\n  line-height: 2;\n}\n\n.material-tip, .material-case, .material-data {\n  background: linear-gradient(90deg, #f7feee 64%, #e7f1e7 100%);\n  color: #115a48;\n  font-size: 16px;\n  border-radius: 9px;\n  padding: 12px 13px 12px 15px;\n  margin-top: 17px;\n  margin-bottom: 8px;\n  box-shadow: 0 0.5px 3px rgba(150,170,153,0.16);\n}\n\n.material-tip {\n  border-left: 6px solid #7ecb86;\n}\n.material-case {\n  border-left: 6px solid #65c3cc;\n  background: linear-gradient(90deg, #eaf7fc 64%, #d6effa 100%);\n}\n.material-case-bg {\n  margin-bottom: 8px;\n}\n.material-data {\n  border-left: 6px solid #ffa15e;\n  background: linear-gradient(90deg, #fff6e7 64%, #ffe7c4 100%);\n}\n.material-emphasis {\n  color: #973217;\n  font-weight: bold;\n  font-size: 16.5px;\n}\n\n.material-ref-box {\n  background: linear-gradient(90deg, #f5f8fb 64%, #ebf2f9 100%);\n  color: #28597a;\n  font-size: 15px;\n  border-radius: 7px;\n  margin-top: 28px;\n  padding: 19px 19px 13px 23px;\n  box-shadow: 0 0.5px 1.5px rgba(80,122,190,0.10);\n}\n.material-ref-list {\n  padding-left: 23px;\n  margin: 9px 0 0 0;\n  color: #386c95;\n}\n.material-ref-list li {\n  margin-bottom: 4px;\n}\n\n.material-bg1 {\n  background: linear-gradient(135deg, #f4fcfa 78%, #e6f2fd 100%);\n}\n.material-bg2 {\n  background: linear-gradient(135deg, #f2f7fa 78%, #e8f7f0 100%);\n}\n.material-bg3 {\n  background: linear-gradient(135deg, #f7fcf4 78%, #f9eee7 100%);\n}\n.material-bg4 {\n  background: linear-gradient(135deg, #f4f9f7 78%, #e6fef2 100%);\n}\n.material-bg5 {\n  background: linear-gradient(135deg, #f7f2fc 78%, #f8eee5 100%);\n}\n.material-bg6 {\n  background: linear-gradient(135deg, #f7fcf5 78%, #e6f1fd 100%);\n}\n.material-bg7 {\n  background: linear-gradient(135deg, #fcf7f4 78%, #fdf1e6 100%);\n}\n.material-bg8 {\n  background: linear-gradient(135deg, #f5f9fc 78%, #f2e8f7 100%);\n}\n.material-bg9 {\n  background: linear-gradient(135deg, #fcf5f7 78%, #fde6f2 100%);\n}\n.material-bg10 {\n  background: linear-gradient(135deg, #f7f8f4 78%, #e6fefb 100%);\n}\n.material-bg11 {\n  background: linear-gradient(135deg, #fcf4fc 78%, #efe7fd 100%);\n}\n.material-bg12 {\n  background: linear-gradient(135deg, #f2f9fb 78%, #f8f7fa 100%);\n}\n.material-bg-end {\n  border: 1.5px dashed #7496c3;\n}\n.material-smooth {\n  transition: background 0.3s;\n}\n\u003C/style>","\u003Cdiv class=\"material-wrapper\">\n  \u003Ch1 id=\"material_title\" class=\"material-title\">乳腺癌二期常用化疗药品实用药指南\u003C/h1",523,"2025-12-06 00:03:32","乳腺癌, 吡柔比星, 环磷酰胺, 化疗药物, 用药指南","探索乳腺癌二期治疗中化疗药品的关键用药细节，包括吡柔比星与环磷酰胺的使用方法与监测要求。保障用药安全与疗效，助力患者健康。","2025-12-15 14:57:21",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]